Throop firefighters selling chicken dinners on Big Game Day
THROOP, LACKAWANNA COUNTY (WBRE/WYOU) — Chicken is on a lot of Big Game menus which has some local firefighters looking to cash in.
Throop Hose Company #1 was busy making and selling chicken dinners.
Volunteers packed up the dinners to go drive-thru style.
Scranton bars, restaurants ready for Big Game Sunday
All of the proceeds benefit Throop Hose Company #1.
'Well, it's important for the company, it's important for the community, not only ours, but for our neighboring company. The money goes right back into maintaining better equipment to help protect the people of the town and their properties,' said Throop Hose Company #1 President Dave Benson.
Throop Hose Company #1 also hopes to bring people to their company to interest them in becoming a volunteer firefighter.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Miami Herald
an hour ago
- Miami Herald
Volkswagen Details 2026 Model Year Updates Ahead Of August Arrival
Volkswagen has announced all the updates for its 2026 lineup, with some 2026 models due to arrive in showrooms in August. Since most models were all-new or significantly refreshed over the last two years, the 2026 updates introduce a few refinements and additional equipment to the VW range. Let's take a closer look at what's new for 2026, starting with the brand's SUV range. The smallest and most affordable VW crossover underwent a comprehensive refresh for the 2025 model year, so for 2026, VW has elected only to add some more equipment. The Taos now gets standard rear-seat pretensioners, while a mid-model year change will see the introduction of upgraded 15-watt wireless charging. Range-topping SEL models now get an upgraded sound system with eight speakers. An all-new Tiguan was introduced for the 2025 model year, featuring a fresh look and a more tech-heavy interior than before. For 2026, the main change is the introduction of the SEL R-Line Turbo, which gets a more powerful 268-horsepower turbocharged engine, up from 201 hp in the other Tiguan models. VW has also updated its Travel Assist and assistant lane change systems; this applies to all trims. Very little has changed for VW's largest SUV models in the USA for 2026. Buyers going for the SE with Technology trim and above now get a factory-installed HomeLink mirror. The Peak Edition, SEL, and SEL Premium R-Line are the other trims benefitting from this change. VW has delayed some of its EV plans, but the ID.4 continues as the brand's sole electric SUV for the 2026 model year. S Plus trims will get a new HomeLink mirror, but VW says a mid-model-year update in 2026 is on the way, when new features will be added to the crossover. No information has been shared on the just yet, following its launch for the 2025 model year, but information on potential upgrades will be announced at a later stage. As with the Taos, rear-seat pretensioners will be standard on 2026 Jettas. The SE gets a standard sunroof, wireless charging is upgraded to 15 w, and SEL variants receive an upgraded eight-speaker sound system. After losing its manual gearbox and getting an updated infotainment system for 2025, there are no major changes for the 2026 Golf GTI. The Golf R underwent similar updates last year, but it's now available with a new exterior color called Graphite Grey Metallic. We expect the manufacturer to share pricing for 2026 models imminently, given that many of them will start arriving in August. The impact of tariffs could come into play here, as VW only promised to freeze pricing of new cars until the end of May. With that freeze now behind us, buyers may be seeing some unwelcome price hikes for 2026, and given how minimal the 2026 MY changes are, it may be a smart move to get a 2025 VW while you still can. Copyright 2025 The Arena Group, Inc. All Rights Reserved.
Yahoo
an hour ago
- Yahoo
Odyssey bails on public listing as US IPO landscape stutters
Odyssey Therapeutics is unlikely to join the 2025 class of biotechs hitting the stock exchanges after the company withdrew its registration statement for an initial public offering (IPO). The autoimmune and inflammatory disease specialist was one in a wave of biotechs to reveal IPO ambitions in January 2025. While Sionna Therapeutics, a biopharma that filed IPO paperwork at the same time, went on to close a nearly $220m IPO in February, Odyssey has bailed on a public listing. Odyssey did not disclose the number of its common stock shares it was offering, nor the price at which the IPO would conduct on each share. The Form S-1, a registration form with the US Securities and Exchange Commission (SEC) for companies carrying out public offerings, only mentioned that the listing would have occurred on the Nasdaq. Odyssey was eyeing an IPO as a way to fund its pipeline, headed by RIPK2 inhibitor OD-07656 that was set for Phase II trials for ulcerative colitis treatment, both as a monotherapy and in combination with Takeda's blockbuster Entyvio (vedolizumab). As per its IPO prospectus in January, the monotherapy trial was set to commence in Q1 2025, with the combo trial slated for the same quarter in 2026. Two pre-clinical programmes also stood to benefit from cash generated from the IPO. In its notice to the SEC outlining the withdrawal of the registration statement, Odyssey stated it is because it is 'not in the best interests of the company to conduct the proposed offering at this time'. The IPO U-turn is the first sign that the health of the IPO landscape could be suffering in the wake of economic fallout from US President Donald Trump's policies. Indeed, it consolidates predictions made by one GlobalData analyst earlier this year. In April, GlobalData business fundamentals analyst Alison Labya said: 'The Trump administration has introduced uncertainty to the biopharmaceutical industry across healthcare policies, drug pricing reforms, and regulatory frameworks, all of which could impact investor confidence. 'Additionally, Trump's recent tariff announcement on imports from Canada, Mexico, and China has led to increased market volatility, potentially delaying IPOs as investors await the countries' responses to the tariffs.' Biotech IPOs saw a strong recovery in 2024, with a total raise of $8.52bn, up 68.4% from $5.06bn raised in 2023. It was the highest total IPO value raised since 2021, with the rebound driven by US Federal Reserve interest rate cuts. The uptick continued into 2025, with Sionna joined by Maze Therapeutics and Metsera Therapeutics. U-turning on IPOs is rare, but Odyssey is not the only biotech to bail on a public listing in the past year. Australian biotech Telix Pharmaceuticals withdrew its US public listing at the last minute in June 2024, also citing unfavourable market conditions at the time. "Odyssey bails on public listing as US IPO landscape stutters" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio
Yahoo
2 hours ago
- Yahoo
Monticello approves $7.5M Oberheim Park contract
MONTICELLO, Ill. (WCIA) — A major multi-million dollar project is officially on track to start in Piatt County. The Monticello City Council passed a contract agreement with an Illinois-based construction company at Monday night's meeting. PREVIOUSLY: Plans moving forward for estimated $8 million Oberheim Park in Monticello It'll start building Phase One of the Oberheim Park complex as soon as next month. It would go in an open field by Route 47 and Green Apple Lane. The price tag came out to $7.5 million, and it officially gets the project to the start coming from the city's general fund and reserves. 'Getting a shovel in the dirt has been a long time coming,' said City Administrator Terry Summers. Now that ground-breaking has a start date, the 35-acres on the west side of Monticello will soon be home to Oberheim Park. '[It'll include] two baseball/softball fields, four youth soccer fields and a multipurpose field,' Summers added. Monday night's city council meeting approved a $7.5 million dollar agreement to break ground by July 1st of this year. The original agreement was for $7.1 million, but the board amended it on Monday to also pay for replacing the plan's asphalt with concrete. SEE ALSO: Monticello moves forward with Oberheim Park plans The board says it came down to getting more bang for their buck in the long term. 'Whereas concrete is going to be a little more upfront in cost, a little longer to install, harder to repair, but it's going to be more pivotal down the road,' said Alderman Ryan Woodham. And it could just be the start for the park. Summers said the city has the flexibility to add further phases and amenities into the future. 'I think the residents want to see some movement out there,' Summers said. 'And I think once you start to see the improvements and start utilizing those improvements and those quality of life amenities, I think there'll be more interest in the park and more interest in possible future phases.' The approval Monday night is expected to fast-track this project, with construction beginning next month and aiming to be mostly complete by next summer. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
